These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21988963)

  • 21. Pharmacogenetics and personalised medicine: maintain a critical approach.
    Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualized drug therapy.
    Daly AK
    Curr Opin Drug Discov Devel; 2007 Jan; 10(1):29-36. PubMed ID: 17265738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the role and impact of molecular markers on treatment decisions for colorectal cancer in the adjuvant setting?
    Al-Salama HM; Johnstone EC; Kerr DJ
    Discov Med; 2009 Oct; 8(42):104-7. PubMed ID: 19833054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 25. [Individualized medicine between expectations and reality].
    Hinneburg I
    Med Monatsschr Pharm; 2011 Jun; 34(6):212-4. PubMed ID: 21812253
    [No Abstract]   [Full Text] [Related]  

  • 26. [Personalized medicine on the upswing].
    Saussele T
    Med Monatsschr Pharm; 2014 Mar; 37(3):81. PubMed ID: 24741847
    [No Abstract]   [Full Text] [Related]  

  • 27. Meeting the technical challenges of personalized medicine and companion diagnostics.
    Montagna RA
    MLO Med Lab Obs; 2012 Jan; 44(1):16, 18, 20 passim. PubMed ID: 22352180
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacogenomics for the primary care provider: why should we care?
    Teng K
    Cleve Clin J Med; 2011 Apr; 78(4):241-2. PubMed ID: 21460129
    [No Abstract]   [Full Text] [Related]  

  • 29. [Introductory remarks by chairpersons].
    Kumagai S; Nobori T
    Rinsho Byori; 2013 May; 61(5):419-20. PubMed ID: 23947181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of pharmacogenetics in clinical practice is challenging.
    van Schie RM; de Boer A; Maitland-van der Zee AH
    Pharmacogenomics; 2011 Sep; 12(9):1231-3. PubMed ID: 21919599
    [No Abstract]   [Full Text] [Related]  

  • 31. US FDA perspective on challenges in co-developing in vitro companion diagnostics and targeted cancer therapeutics.
    Philip R; Carrington L; Chan M
    Bioanalysis; 2011 Feb; 3(4):383-9. PubMed ID: 21338257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
    Picker A; Jackson DB
    Expert Rev Mol Diagn; 2011 Jul; 11(6):567-77. PubMed ID: 21745011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

  • 34. Introduction. Personalizing patient care with precision medicine.
    Wujcik D; Knoop T
    Semin Oncol Nurs; 2014 May; 30(2):81-3. PubMed ID: 24794081
    [No Abstract]   [Full Text] [Related]  

  • 35. A fast track to personalized medicine?: whole-genome sequencing may lead to better cancer therapies.
    Nelson B
    Cancer Cytopathol; 2012 Oct; 120(5):283-4. PubMed ID: 23065928
    [No Abstract]   [Full Text] [Related]  

  • 36. The second wave in kinase cancer drugs.
    Garber K
    Nat Biotechnol; 2006 Feb; 24(2):127-30. PubMed ID: 16465146
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress?
    Topol EJ
    Sci Transl Med; 2010 Aug; 2(44):44cm22. PubMed ID: 20702854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Getting to personalized cancer medicine: taking out the garbage.
    Compton C
    Cancer; 2007 Oct; 110(8):1641-3. PubMed ID: 17763370
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenetics and personalized medicine.
    Li-Wan-Po A
    J Clin Pharm Ther; 2012 Dec; 37(6):617-9. PubMed ID: 23013532
    [No Abstract]   [Full Text] [Related]  

  • 40. [Individualized cancer therapy and treatment based on syndrome differentiation].
    Wang ZY
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):158-60. PubMed ID: 23714675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.